This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring

€500 savings end in:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
THE SPRINGTIME PARTNERING EVENT
March 18–20, 2024 | Barcelona, SpainMarch 26–27, 2024 | Digital Partnering

Virica Biotech

Profile

We believe that current viral vector optimization technologies fall short because they fail to address a fundamental challenge, innate cellular antiviral defenses. Viral vectors used in gene therapy and vaccine applications trigger these antiviral defenses which prevents optimal production, leading to lower yield, efficiency, and limited scalability. Virica has developed a unique approach to addressing this challenge, a platform of Viral Sensitizers (VSETM) which help reduce antiviral defenses thereby increasing yield and improving critical quality attributes.